Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccine value profile for Shigella.
Hausdorff WP, Anderson JD 4th, Bagamian KH, Bourgeois AL, Mills M, Sawe F, Scheele S, Talaat K, Giersing BK. Hausdorff WP, et al. Vaccine. 2023 Nov 3;41 Suppl 2:S76-S94. doi: 10.1016/j.vaccine.2022.12.037. Epub 2023 Oct 10. Vaccine. 2023. PMID: 37827969 Free article.
Exploring Shigella vaccine priorities and preferences: Results from a mixed-methods study in low- and middle-income settings.
Fleming JA, Gurley N, Knudson S, Kabore L, Bawa JT, Dapaah P, Kumar S, Uranw S, Tran T, Mai LTP, Odero C, Obong'o C, Aburam K, Wanjiru S, Hanh NTM, Dung LP, Hausdorff WP. Fleming JA, et al. Among authors: hausdorff wp. Vaccine X. 2023 Aug 9;15:100368. doi: 10.1016/j.jvacx.2023.100368. eCollection 2023 Dec. Vaccine X. 2023. PMID: 37636544 Free PMC article.
Vaccine value profile for enterotoxigenic Escherichia coli (ETEC).
Khalil I, Anderson JD, Bagamian KH, Baqar S, Giersing B, Hausdorff WP, Marshall C, Porter CK, Walker RI, Bourgeois AL. Khalil I, et al. Among authors: hausdorff wp. Vaccine. 2023 Nov 3;41 Suppl 2:S95-S113. doi: 10.1016/j.vaccine.2023.02.011. Epub 2023 Oct 6. Vaccine. 2023. PMID: 37951695 Free article.
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of abstract-based presentations.
Banerjee S, Barry EM, Baqar S, Louis Bourgeois A, Campo JJ, Choy RKM, Chakraborty S, Clifford A, Deal C, Estrada M, Fleckenstein J, Hasso-Agopsowicz M, Hausdorff W, Khalil I, Maier N, Mubanga C, Platts-Mills JA, Porter C, Qadri F, Simuyandi M, Walker R, White JA. Banerjee S, et al. Vaccine. 2024 Mar 7;42(7):1454-1460. doi: 10.1016/j.vaccine.2023.11.031. Epub 2023 Nov 28. Vaccine. 2024. PMID: 38030421 Free PMC article. Review.
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops.
Baqar S, Bonavia A, Louis Bourgeois A, Campo JJ, Clifford A, Hanevik K, Hasso-Agopsowicz M, Hausdorff W, Kaminski R, MacLennan CA, Mantis N, Martin LB, Omore R, Pasetti M, Pavlinac P, Phalipon A, Poly F, Porter C, Ramasamy MN, Rogawski McQuade ET, Sztein MB, Walker R. Baqar S, et al. Vaccine. 2024 Mar 7;42(7):1445-1453. doi: 10.1016/j.vaccine.2023.11.045. Epub 2023 Nov 30. Vaccine. 2024. PMID: 38036392 Free PMC article.
Reassessing potential economic value and health impact of effective Shigella vaccines.
Hausdorff WP, Anderson JD 4th, Bourgeois AL, Clifford A, Fleming JA, Muhib F, Pecenka C, Puett C, Riddle MS, Scheele S, Bagamian KH. Hausdorff WP, et al. Bull World Health Organ. 2024 Jan 1;102(1):65-74. doi: 10.2471/BLT.23.290163. Epub 2023 Dec 11. Bull World Health Organ. 2024. PMID: 38164339 Free PMC article.
98 results